Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of Aurora kinase A and B presented

Dec. 21, 2010

New inhibitors CK II and/or pim-1 discovered at Cylene Pharma

Dec. 21, 2010

FDA grants fast track status for elacytarabine in AML

Dec. 21, 2010

MRx-102 shows promise in models of AML

Dec. 21, 2010

NS-018 preferentially targets V617F-mutant JAK2

Dec. 21, 2010

Clinical and preclinical data presented on GDC-0941/T-DM1 in HER2+ breast cancer

Dec. 21, 2010

Panobinostat/capecitabine/lapatinib combination is safe in HER2+ breast cancer

Dec. 21, 2010

ClanoTech divulges new inhibitors of VEGFR-2 and VEGFR-3

Dec. 21, 2010

UCB claims new PI3K inhibitors

Dec. 21, 2010

Enzon and NCI begin phase I trials of EZN-2968 and EZN-2208

Dec. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...